Vous êtes ici

Neural Therapeutics Inc.

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Diversified Industries
Symbole: 
NURL
Indice CSE: 
Devise: 

Neural Therapeutics is an ethnobotanical drug discovery company, focusing on the development of therapeutic drugs for mental illnesses related to substance use disorders, including alcohol and opioid dependence. The Company’s innovative approach to drug development involves the strategic use of sub-hallucinogenic doses of mescaline extract, enhancing safety and scalability while maintaining therapeutic efficacy.

Neural Therapeutics Inc. (NURL)

Information d'entreprise

Addresse
3002-130 Adelaide St. W.
Toronto, ON M5H 3P5
Canada
Téléphone
647-697-6875
Courriel
info@neuraltherapeutics.com
URL
http://www.neuraltherapeutics.ca
Date d’inscription à la cote
Lundi, mars 17, 2025
Agent de transfert
Odyssey Trust Company

SEDAR Information

Information d'entreprise

Addresse
3002-130 Adelaide St. W.
Toronto, ON M5H 3P5
Canada
Téléphone
647-697-6875
Courriel
info@neuraltherapeutics.com
URL
http://www.neuraltherapeutics.ca
Date d’inscription à la cote
Lundi, mars 17, 2025
Agent de transfert
Odyssey Trust Company

Capitalisation

Capitalisation: 
88700524
Réservé à l'émission: 
31203436

Company Officers

Ian Campbell, Chief Executive Officer
Omar Gonzalez, Chief Financial Officer